Jump Financial’s Mustang Bio MBIO Stock Holding History

Jump Financial’s Portfolio MBIO Stock Details MBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-215	Closed	-$2.53K	–	1857
2024 Q3	$2.53K	Sell	215 -27	-11%	-$446	﹤0.01%	1575
2024 Q2	$5.73K	Buy	+242	New	+$4.6K	﹤0.01%	1738
2021 Q2	–	Sell	-64	Closed	-$159K	–	1273
2021 Q1	$159K	Buy	+64	New	+$190K	0.01%	791

Other funds holding MBIO

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HWM

HB Wealth Management Atlanta, Georgia $15.5B AUM 18.35% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Jump Financial's MBIO Position: Q4 2024 in Review

Jump Financial sold out of Mustang Bio (MBIO) in Q4 2024, closing a stake of 215 shares — an estimated $2.53K sold.

Jump Financial first reported a position in MBIO in Q1 2021 and held it in 3 quarters. The position peaked at $159K in Q1 2021. 30 funds tracked by Wall St. Rank hold MBIO as of Q4 2024.

Jump Financial reported no remaining Mustang Bio position as of Q4 2024 after selling out during the quarter.
Jump Financial sold 215 Mustang Bio shares in Q4 2024, an estimated $2.53K.
Jump Financial first reported a position in Mustang Bio in Q1 2021 and held it in 3 quarters.
Jump Financial's Mustang Bio position peaked at $159K in Q1 2021.
30 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2024.

Based on Jump Financial's 13F filing for Q4 2024, filed 13 Feb 2025.